Artivion, Inc. (AORT)
USD 27.79
(-3.84%)
USD 27.79
(-3.84%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 223.43 Million USD | 1.46% |
| 2022 | 196.32 Million USD | -4.38% |
| 2021 | 205.32 Million USD | 24.18% |
| 2020 | 165.34 Million USD | -0.38% |
| 2019 | 165.97 Million USD | 1.4% |
| 2018 | 163.67 Million USD | 35.63% |
| 2017 | 120.67 Million USD | 14.93% |
| 2016 | 104.99 Million USD | 22.99% |
| 2015 | 85.36 Million USD | 3.53% |
| 2014 | 82.45 Million USD | 7.69% |
| 2013 | 76.56 Million USD | 5.75% |
| 2012 | 72.4 Million USD | 12.78% |
| 2011 | 64.2 Million USD | 16.76% |
| 2010 | 54.98 Million USD | -0.52% |
| 2009 | 55.27 Million USD | 1.87% |
| 2008 | 54.25 Million USD | 6.55% |
| 2007 | 50.92 Million USD | 12.93% |
| 2006 | 45.09 Million USD | -20.82% |
| 2005 | 56.94 Million USD | 22.27% |
| 2004 | 46.57 Million USD | -18.68% |
| 2003 | 57.27 Million USD | 9.87% |
| 2002 | 52.12 Million USD | 35.11% |
| 2001 | 38.58 Million USD | 3.82% |
| 2000 | 37.16 Million USD | 15.25% |
| 1999 | 32.24 Million USD | 0.45% |
| 1998 | 32.1 Million USD | 18.45% |
| 1997 | 27.1 Million USD | 36.18% |
| 1996 | 19.9 Million USD | 21.34% |
| 1995 | 16.4 Million USD | 16.31% |
| 1994 | 14.1 Million USD | 13.71% |
| 1993 | 12.4 Million USD | 27.84% |
| 1992 | 9.7 Million USD | 10.23% |
| 1991 | 8.8 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 33.76 Million USD | -41.7% |
| 2024 Q2 | 51.1 Million USD | 51.35% |
| 2023 Q2 | 64.65 Million USD | 12.28% |
| 2023 Q4 | 57.92 Million USD | 0.71% |
| 2023 FY | 199.19 Million USD | 1.46% |
| 2023 Q1 | 57.58 Million USD | 23.16% |
| 2023 Q3 | 57.51 Million USD | -11.05% |
| 2022 FY | 196.32 Million USD | -4.38% |
| 2022 Q1 | 49.08 Million USD | -19.16% |
| 2022 Q2 | 47.63 Million USD | -2.96% |
| 2022 Q3 | 52.85 Million USD | 10.96% |
| 2022 Q4 | 46.75 Million USD | -11.53% |
| 2021 Q1 | 46.39 Million USD | 8.7% |
| 2021 Q2 | 49.19 Million USD | 6.03% |
| 2021 Q3 | 49.02 Million USD | -0.34% |
| 2021 Q4 | 60.71 Million USD | 23.84% |
| 2021 FY | 205.32 Million USD | 24.18% |
| 2020 FY | 165.34 Million USD | -0.38% |
| 2020 Q3 | 39.49 Million USD | 4.46% |
| 2020 Q1 | 45.35 Million USD | 5.68% |
| 2020 Q2 | 37.81 Million USD | -16.64% |
| 2020 Q4 | 42.67 Million USD | 8.05% |
| 2019 Q2 | 40.46 Million USD | -3.81% |
| 2019 FY | 165.97 Million USD | 1.4% |
| 2019 Q1 | 42.06 Million USD | -0.81% |
| 2019 Q3 | 40.51 Million USD | 0.13% |
| 2019 Q4 | 42.92 Million USD | 5.93% |
| 2018 Q2 | 40.44 Million USD | -5.32% |
| 2018 Q4 | 42.41 Million USD | 11.33% |
| 2018 Q3 | 38.09 Million USD | -5.81% |
| 2018 FY | 163.67 Million USD | 35.63% |
| 2018 Q1 | 42.71 Million USD | 16.85% |
| 2017 Q4 | 36.55 Million USD | 25.92% |
| 2017 Q3 | 29.03 Million USD | 3.26% |
| 2017 FY | 120.67 Million USD | 14.93% |
| 2017 Q2 | 28.11 Million USD | 4.28% |
| 2017 Q1 | 26.96 Million USD | 3.35% |
| 2016 Q2 | 25.71 Million USD | -10.97% |
| 2016 FY | 104.99 Million USD | 22.99% |
| 2016 Q1 | 28.88 Million USD | 33.23% |
| 2016 Q4 | 26.09 Million USD | 7.34% |
| 2016 Q3 | 24.3 Million USD | -5.48% |
| 2015 Q3 | 20.45 Million USD | -7.07% |
| 2015 Q2 | 22.01 Million USD | 3.72% |
| 2015 Q4 | 21.67 Million USD | 5.99% |
| 2015 FY | 85.36 Million USD | 3.53% |
| 2015 Q1 | 21.22 Million USD | 2.37% |
| 2014 Q4 | 20.73 Million USD | -0.26% |
| 2014 Q3 | 20.78 Million USD | 3.09% |
| 2014 Q1 | 20.77 Million USD | 8.5% |
| 2014 Q2 | 20.16 Million USD | -2.96% |
| 2014 FY | 82.45 Million USD | 7.69% |
| 2013 Q1 | 19.96 Million USD | 5.97% |
| 2013 Q2 | 18.66 Million USD | -6.5% |
| 2013 FY | 76.56 Million USD | 5.75% |
| 2013 Q4 | 19.14 Million USD | 1.94% |
| 2013 Q3 | 18.78 Million USD | 0.62% |
| 2012 Q4 | 18.84 Million USD | 2.6% |
| 2012 Q3 | 18.36 Million USD | 18.15% |
| 2012 Q2 | 15.54 Million USD | -20.96% |
| 2012 Q1 | 19.66 Million USD | 19.71% |
| 2012 FY | 72.4 Million USD | 12.78% |
| 2011 Q1 | 16.05 Million USD | 12.78% |
| 2011 Q4 | 16.42 Million USD | 0.06% |
| 2011 Q2 | 15.3 Million USD | -4.7% |
| 2011 Q3 | 16.41 Million USD | 7.28% |
| 2011 FY | 64.2 Million USD | 16.76% |
| 2010 Q4 | 14.23 Million USD | 11.85% |
| 2010 Q1 | 15.1 Million USD | 8.09% |
| 2010 Q2 | 12.91 Million USD | -14.55% |
| 2010 Q3 | 12.73 Million USD | -1.39% |
| 2010 FY | 54.98 Million USD | -0.52% |
| 2009 Q1 | 13.77 Million USD | 0.5% |
| 2009 Q3 | 13.84 Million USD | 101172.58% |
| 2009 FY | 55.27 Million USD | 1.87% |
| 2009 Q4 | 13.97 Million USD | 0.95% |
| 2009 Q2 | 13.67 Thousand USD | -99.9% |
| 2008 Q3 | 13.25 Million USD | -2.98% |
| 2008 Q1 | 13.51 Million USD | 1.05% |
| 2008 FY | 54.25 Million USD | 6.55% |
| 2008 Q2 | 13.66 Million USD | 1.13% |
| 2008 Q4 | 13.7 Million USD | 3.37% |
| 2007 FY | 50.92 Million USD | 12.93% |
| 2007 Q4 | 13.37 Million USD | 8.38% |
| 2007 Q3 | 12.33 Million USD | 4.38% |
| 2007 Q2 | 11.82 Million USD | -11.74% |
| 2007 Q1 | 13.39 Million USD | 7.89% |
| 2006 FY | 45.09 Million USD | -20.82% |
| 2006 Q4 | 12.41 Million USD | 32.42% |
| 2006 Q3 | 9.37 Million USD | -15.4% |
| 2006 Q2 | 11.08 Million USD | -9.32% |
| 2006 Q1 | 12.22 Million USD | 6.46% |
| 2005 FY | 56.94 Million USD | 22.27% |
| 2005 Q1 | 10.97 Million USD | -7.71% |
| 2005 Q3 | 11.97 Million USD | -46.79% |
| 2005 Q4 | 11.47 Million USD | -4.17% |
| 2005 Q2 | 22.51 Million USD | 105.1% |
| 2004 Q4 | 11.89 Million USD | -8.73% |
| 2004 Q2 | 10.58 Million USD | -4.38% |
| 2004 Q1 | 11.06 Million USD | 26.65% |
| 2004 FY | 46.57 Million USD | -18.68% |
| 2004 Q3 | 13.03 Million USD | 23.12% |
| 2003 FY | 57.27 Million USD | 9.87% |
| 2003 Q4 | 8.74 Million USD | -23.32% |
| 2003 Q3 | 11.39 Million USD | -53.72% |
| 2003 Q1 | 12.5 Million USD | -23.32% |
| 2003 Q2 | 24.62 Million USD | 96.87% |
| 2002 Q4 | 16.31 Million USD | 30.09% |
| 2002 Q3 | 12.54 Million USD | -0.81% |
| 2002 Q2 | 12.64 Million USD | 18.93% |
| 2002 Q1 | 10.63 Million USD | 2.14% |
| 2002 FY | 52.12 Million USD | 35.11% |
| 2001 Q1 | 9.24 Million USD | -2.57% |
| 2001 FY | 38.58 Million USD | 3.82% |
| 2001 Q4 | 10.4 Million USD | 9.3% |
| 2001 Q3 | 9.52 Million USD | 1.23% |
| 2001 Q2 | 9.4 Million USD | 1.74% |
| 2000 FY | 37.16 Million USD | 15.25% |
| 2000 Q4 | 9.48 Million USD | 4.41% |
| 2000 Q1 | 9.15 Million USD | 7.15% |
| 2000 Q2 | 9.39 Million USD | 2.63% |
| 2000 Q3 | 9.08 Million USD | -3.27% |
| 1999 Q2 | 7.6 Million USD | -5.0% |
| 1999 Q1 | 8 Million USD | -9.09% |
| 1999 Q4 | 8.54 Million USD | 4.18% |
| 1999 Q3 | 8.2 Million USD | 7.89% |
| 1999 FY | 32.24 Million USD | 0.45% |
| 1998 FY | 32.1 Million USD | 18.45% |
| 1998 Q1 | 7.8 Million USD | 8.33% |
| 1998 Q2 | 7.9 Million USD | 1.28% |
| 1998 Q3 | 7.5 Million USD | -5.06% |
| 1998 Q4 | 8.8 Million USD | 17.33% |
| 1997 Q1 | 5.8 Million USD | 18.37% |
| 1997 FY | 27.1 Million USD | 36.18% |
| 1997 Q3 | 6.8 Million USD | -5.56% |
| 1997 Q4 | 7.2 Million USD | 5.88% |
| 1997 Q2 | 7.2 Million USD | 24.14% |
| 1996 Q4 | 4.9 Million USD | -5.77% |
| 1996 Q3 | 5.2 Million USD | 0.0% |
| 1996 Q2 | 5.2 Million USD | 13.04% |
| 1996 Q1 | 4.6 Million USD | 6.98% |
| 1996 FY | 19.9 Million USD | 21.34% |
| 1995 Q2 | 4 Million USD | 5.26% |
| 1995 Q3 | 4.4 Million USD | 10.0% |
| 1995 Q4 | 4.3 Million USD | -2.27% |
| 1995 FY | 16.4 Million USD | 16.31% |
| 1995 Q1 | 3.8 Million USD | 0.0% |
| 1994 Q2 | 3.4 Million USD | 6.25% |
| 1994 Q4 | 3.8 Million USD | 5.56% |
| 1994 FY | 14.1 Million USD | 13.71% |
| 1994 Q1 | 3.2 Million USD | -8.57% |
| 1994 Q3 | 3.6 Million USD | 5.88% |
| 1993 Q2 | 2.9 Million USD | 0.0% |
| 1993 FY | 12.4 Million USD | 27.84% |
| 1993 Q1 | - USD | 100.0% |
| 1993 Q3 | 3.5 Million USD | 20.69% |
| 1993 Q4 | 3.5 Million USD | 0.0% |
| 1992 FY | 9.7 Million USD | 10.23% |
| 1992 Q1 | - USD | 100.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q4 | -18.5 Million USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | -15.9 Million USD | 0.0% |
| 1991 FY | 8.8 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Abbott Laboratories | 15.71 Billion USD | 98.578% |
| Allurion Technologies Inc. | 120.57 Million USD | -85.307% |
| Avanos Medical, Inc. | 375.5 Million USD | 40.497% |
| Butterfly Network, Inc. | 162.46 Million USD | -37.527% |
| Butterfly Network, Inc. | 162.46 Million USD | -37.527% |
| Bio-Rad Laboratories, Inc. | 1.04 Billion USD | 78.671% |
| Boston Scientific Corporation | 7.47 Billion USD | 97.012% |
| Perspective Therapeutics, Inc. | 17.42 Million USD | -1182.188% |
| CONMED Corporation | 564.24 Million USD | 60.401% |
| Edwards Lifesciences Corporation | 3.09 Billion USD | 92.771% |
| Paragon 28, Inc. | 210.1 Million USD | -6.347% |
| Glaukos Corporation | 367.83 Million USD | 39.257% |
| Globus Medical, Inc. | 887.16 Million USD | 74.815% |
| Inspire Medical Systems, Inc. | 568.49 Million USD | 60.697% |
| Integer Holdings Corporation | 250.95 Million USD | 10.968% |
| Medtronic plc | 16.12 Billion USD | 98.615% |
| Nevro Corp. | 389.36 Million USD | 42.616% |
| Owlet, Inc. | 51.21 Million USD | -336.233% |
| Penumbra, Inc. | 590.87 Million USD | 62.186% |
| Vicarious Surgical Inc. | 80.66 Million USD | -176.987% |
| Smith & Nephew plc | 3.46 Billion USD | 93.555% |
| Sonendo, Inc. | 68.46 Million USD | -226.348% |
| STERIS plc | 1.4 Billion USD | 84.045% |
| Stryker Corporation | 9.2 Billion USD | 97.574% |
| Vapotherm, Inc. | 66.02 Million USD | -238.408% |
| Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | 93.18% |